{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:00:39Z","timestamp":1775523639299,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015747","name":"University Grants Commission of Bangladesh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.05.079","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T17:54:40Z","timestamp":1591811680000},"page":"4970-4978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine"],"prefix":"10.1016","volume":"38","author":[{"given":"Md.","family":"Al Amin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rahmat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rafiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.M. Rubayet Ul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipok Kumer","family":"Shill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Shaminur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Anwar","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munawar","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Anwar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2020.05.079_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9975(03)00041-0","article-title":"The pathogenesis and diagnosis of foot-and-mouth disease","volume":"129","author":"Alexandersen","year":"2003","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2020.05.079_b0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1297-9716-45-51","article-title":"Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine","volume":"45","author":"Li","year":"2014","journal-title":"Vet Res"},{"issue":"44","key":"10.1016\/j.vaccine.2020.05.079_b0015","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1016\/j.vaccine.2014.08.033","article-title":"Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains","volume":"32","author":"Bari","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.079_b0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/lam.12354","article-title":"Re-emergence of circulatory foot-and-mouth disease virus serotypes Asia1 in Bangladesh and VP1 protein heterogeneity with vaccine strain IND 63\/72","volume":"60","author":"Ullah","year":"2015","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.079_b0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/tbed.12834","article-title":"Emergence of two novel sublineages Ind 2001 BD 1 and Ind2001 BD 2 of foot-and-mouth disease virus serotype O in Bangladesh","volume":"65","author":"Siddique","year":"2018","journal-title":"Transboundary Emerging Diseases"},{"key":"10.1016\/j.vaccine.2020.05.079_b0030","doi-asserted-by":"crossref","unstructured":"Ali MR, ASMRU Alam, MA Amin, MA Siddique, M Sultana, and MA Hossain, (2019).Emergence of novel lineage of foot\u2010and\u2010mouth disease virus serotype Asia1 BD\u201018 (G\u2010IX) in Bangladesh. Transbound Emerg Dis. 00:1\u20138. https :\/\/doi.org\/10.1111\/tbed.13381.","DOI":"10.1101\/604892"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.079_b0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3329\/bjvm.v8i2.11199","article-title":"Standardization of multiplex reverse transcriptase polymerase chain reaction and typing of foot and mouth disease virus prevalent in Bangladesh","volume":"8","author":"Zinnah","year":"2010","journal-title":"Bangl J Vet Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.079_b0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/tbed.12113","article-title":"Emergence and distribution of foot-and-mouth disease virus serotype A and O in Bangladesh","volume":"62","author":"Nandi","year":"2013","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2020.05.079_b0045","doi-asserted-by":"crossref","unstructured":"Sultana M, MA Siddique, S Momtaz, A Rahman, H Ullah, SP Nandi, and MA Hossain, (2014).Complete Genome Sequence of Foot-and-Mouth Disease Virus Serotype O Isolated from Bangladesh. Genome Announc 2(1):e01253-13(1).","DOI":"10.1128\/genomeA.01253-13"},{"key":"10.1016\/j.vaccine.2020.05.079_b0050","doi-asserted-by":"crossref","unstructured":"Ullah H, MA Siddique, M Sultana, and MA Hossain, (2014).Complete genome sequence of foot-and-mouth disease virus type A circulating in Bangladesh. Genome Announc 2(3):e00506-14(3).","DOI":"10.1128\/genomeA.00506-14"},{"key":"10.1016\/j.vaccine.2020.05.079_b0055","doi-asserted-by":"crossref","unstructured":"Ali MR, H Ullah, MA Siddique, M Sultana, and MA Hossain, (2016).Complete Genome Sequence of Pig-Originated Foot-and-Mouth Disease Virus Serotype O from Bangladesh. Genome Announc 4(5):e01150-16(5).","DOI":"10.1128\/genomeA.01150-16"},{"issue":"43","key":"10.1016\/j.vaccine.2020.05.079_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01135-17","article-title":"Complete genome sequence of the circulatory foot-and-mouth disease virus serotype Asia1 in Bangladesh","volume":"5","author":"Ali","year":"2017","journal-title":"Genome Announc"},{"issue":"37","key":"10.1016\/j.vaccine.2020.05.079_b0065","first-page":"e00031","article-title":"Near-complete genome sequence of a potential foot-and-mouth disease virus serotype A vaccine strain isolated from Bangladesh","volume":"8","author":"Al Amin","year":"2019","journal-title":"Microbiol Resource Announc"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.079_b0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/tbed.12113","article-title":"Emergence and Distribution of Foot-and-Mouth Disease Virus Serotype A and O in Bangladesh","volume":"62","author":"Nandi","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.05.079_b0075","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"issue":"19","key":"10.1016\/j.vaccine.2020.05.079_b0080","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/bioinformatics\/btq429","article-title":"Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology","volume":"26","author":"Delport","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.079_b0085","first-page":"107","article-title":"Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains","volume":"81","author":"Rweyemamu","year":"1978","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.079_b0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0264-410X(90)90083-X","article-title":"Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine","volume":"8","author":"Bahnemann","year":"1990","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.079_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biologicals.2004.09.001","article-title":"Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine","volume":"32","author":"Aarthi","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.05.079_b0100","unstructured":"OIE, (2012).Chapter 2.1.5. Foot and Mouth Disease. OIE Terrestrial Manual"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.079_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0376-7388(97)00056-2","article-title":"Concentration of foot-and-mouth disease virus by ultrafiltration","volume":"132","author":"Adikane","year":"1997","journal-title":"J Membr Sci"},{"issue":"41","key":"10.1016\/j.vaccine.2020.05.079_b0110","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/j.vaccine.2011.05.078","article-title":"Foot and mouth disease (FMD) virus: Quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography","volume":"29","author":"Spitteler","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.079_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5958\/0973-9149.2015.00004.0","article-title":"Screening of Anti-nonstructural Protein Antibodies against FMD Virus using 3AB3 Recombinant Protein-Based DIVA ELISA in Uttar Pradesh","volume":"17","author":"Singh","year":"2015","journal-title":"Journal of Immunology and Immunopathology"},{"issue":"51","key":"10.1016\/j.vaccine.2020.05.079_b0120","first-page":"7147","article-title":"Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007\u20132012) circulating in Southeast Asia","volume":"35","author":"Mahapatra","year":"2017","journal-title":"East Asia and Far East. Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.079_b0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven behandlung pharmakologischer reihenversuche","volume":"162","author":"K\u0201rber","year":"1931","journal-title":"Archive f\u00fcr Experimentelle Pathologie Pharmakologie"},{"key":"10.1016\/j.vaccine.2020.05.079_b0130","doi-asserted-by":"crossref","unstructured":"Sharma GK, Sonalika Mahajan, Rakesh Matura, Saravanan Subramaniam, Jajati K. Mohapatra, and B Pattnaik, (2015).Quantitative single dilution liquid phase blocking ELISA for seromonitoring of foot-and-mouth disease in India. Biologicals 43: p. 158-164.","DOI":"10.1016\/j.biologicals.2015.03.003"},{"key":"10.1016\/j.vaccine.2020.05.079_b0135","doi-asserted-by":"crossref","unstructured":"Wickham H, (2011).ggplot2. Wiley Interdisciplinary Reviews: Computational Statistics 3(2): p. 180-185.","DOI":"10.1002\/wics.147"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.079_b0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/tbed.13372","article-title":"First detection of foot-and-mouth disease virus O\/ME-SA\/Ind2001e sublineage in Jordan","volume":"67","author":"Ababneh","year":"2020","journal-title":"Transboundary and Emerging Diseases"},{"issue":"49","key":"10.1016\/j.vaccine.2020.05.079_b0145","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1016\/j.vaccine.2017.10.040","article-title":"Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain","volume":"35","author":"Lloyd-Jones","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.079_b0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.vaccine.2014.11.058","article-title":"Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O\/IND\/R2\/75 against currently circulating viruses","volume":"33","author":"Mahapatra","year":"2015","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2020.05.079_b0155","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2016.02.057","article-title":"Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions","volume":"34","author":"Mahapatra","year":"2016","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2020.05.079_b0160","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/S0264-410X(03)00219-6","article-title":"Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach","volume":"21","author":"Barnett","year":"2003","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2020.05.079_b0165","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1016\/j.vaccine.2013.05.078","article-title":"Montanide ISA\u2122 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle","volume":"31","author":"Dar","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2020.05.079_b0170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.14202\/vetworld.2015.1189-1198","article-title":"Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine","volume":"8","author":"Ibrahim","year":"2015","journal-title":"Veterinary World"},{"issue":"31","key":"10.1016\/j.vaccine.2020.05.079_b0175","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.vaccine.2008.05.013","article-title":"Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative","volume":"26","author":"Goris","year":"2008","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2020.05.079_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.vetmic.2014.01.005","article-title":"Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies","volume":"169","author":"Patil","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.079_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.trivac.2016.04.006","article-title":"Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge","volume":"5","author":"Park","year":"2016","journal-title":"Trials in Vaccinology"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.079_b0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1135(02)00046-9","article-title":"Early antibody responses of cattle for foot-and-mouth disease quadrivalent double oil emulsion vaccine","volume":"87","author":"Patil","year":"2002","journal-title":"Vet Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.079_b0195","doi-asserted-by":"crossref","first-page":"844","DOI":"10.14202\/vetworld.2013.844-851","article-title":"Preparation of Foot and Mouth Disease trivalent vaccine type A, O, SAT2 with determination of the Guinea pig protective dose 50 (GPPD50)","volume":"6","author":"Daoud","year":"2013","journal-title":"Veterinary World"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:23Z","timestamp":1759401803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":39,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307349"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}